Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-043364
Filing Date
2017-02-14
Accepted
2017-02-14 16:07:29
Documents
3
Group Members
DANIEL HOPPDH-CAPITAL GMBH & CO. KGDIETMAR HOPPDR. MATHIAS HOTHUMOH BETEILIGUNGEN GMBH & CO. KGOLIVER HOPPPROF. DR. CHRISTOF HETTICHPROF. DR. FRIEDRICH VON BOHLEN UND HALBACH

Document Format Files

Seq Description Document Type Size
1 SC 13G d302629dsc13g.htm SC 13G 191570
2 EX-99.1 d302629dex991.htm EX-99.1 15464
3 EX-99.2 d302629dex992.htm EX-99.2 10435
  Complete submission text file 0001193125-17-043364.txt   219258
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89853 | Film No.: 17608692
SIC: 2834 Pharmaceutical Preparations

Mailing Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190
Business Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190 62278608462
dievini Hopp BioTech holding GmbH & Co KG (Filed by) CIK: 0001696029 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G